𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model

✍ Scribed by Jason S. Lewis; Mu Wang; Richard Laforest; Fan Wang; Jack L. Erion; Joseph E. Bugaj; Ananth Srinivasan; Carolyn J. Anderson


Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
84 KB
Volume
94
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Radiolabeled somatostatin analogs have demonstrated effectiveness for targeted radiotherapy of somatostatin receptor-positive tumors in both tumor-bearing rodent models and humans. A radionuclide of interest for cancer therapy is reactor-produced 177 Lu (t 1/2 ‫؍‬ 6.64 d; ␤ ؊ [100%]). The high therapeutic efficacy of the somatostatin analog 177 Lu-DOTA-Tyr 3 -octreotate (DOTA-Y3-TATE, where DOTA is 1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid) was previously demonstrated in a tumor-bearing rat model (Erion et al.,


📜 SIMILAR VOLUMES


Anti-tumor effect and increased survival
✍ Wouter A.P. Breeman; Amir Mearadji; Astrid Capello; Bert F. Bernard; Casper H.J. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 82 KB

## Abstract Peptide receptor scintigraphy with [^111^In‐DTPA^0^]octreotide (a stabilized radiolabeled somatostatin (SS) analogue, OctreoScan®) is widely used for the visualization and staging of somatostatin receptor‐positive tumors. The application of likewise somatostatin analogues as vehicle for

Blood–brain barrier permeability to mang
✍ Emmanuelle Grillon; Peggy Provent; Olivier Montigon; Christoph Segebarth; Chanta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB

## Abstract Loss of integrity of the blood–brain barrier (BBB) and brain swelling is a potentially lethal complication of reperfusion in human stroke. To assess the time course of BBB modifications, we performed angiography, diffusion‐weighted imaging, __T__1‐weighted (__T__~1~W) imaging and __T__~